Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Revista Colombiana de Nefrología
On-line version ISSN 2500-5006
Abstract
SAENZ, Jorge Armando Pulido; TRUJILLO, Javier; DIAZ, Laura and BARBA, Nelson. Angiotensin Converting Enzime Receptor and COVID-19 Correlation ¿What do we know so far?. Rev. colom. nefrol. [online]. 2020, vol.7, suppl.2, pp.280-284. Epub May 12, 2021. ISSN 2500-5006. https://doi.org/10.22265/acnef.7.supl.2.426.
Introduction:
As a new disease, SARS-COV-2 is a new challenge for healthcare system worldwide, with physiopathology under study and controversy about Angiotensin Converting Enzyme Blockers use because of It's physiopatological correlation with SARS-Cov-2.
Objetive:
Search for novel literature and recent recomendations about use of Angiotensin Converting Enzyme Blockers during Covid-19 illness.
Materials and Methods:
We look for narrative literature at PubMed Database for articles about Angiotensin Converting Enzyme and Covid-19 pandemic. Searching limit was April 13 of2.020, we included all languages.
Results.
We included 14 articles with significative scientific content for review objetive.
Conclusion:
SARS-Cov-2 Physiopatology is still unclear, also, pharmacology effectiveness in it’s treatment. One of these pharmacology groups are the Angiotensin Converting Enzyme Blockers with uncertainty about it’s safety during COVID-19 illness.
Keywords : Angiotensin Receptors; COVID-19; severe acute respiratory syndrome; SARS-CoV-2; coronavirus infection (MeSH).
